<%@LANGUAGE="JAVASCRIPT" CODEPAGE="936"%> 北京百慧生化制药有限责任公司
 
公司简介
 
现代化生产车间
证书
证书
证书


公司简介

The Profile of Beijing Baihui
Biochemical Pharmaceutical Co.,Ltd.  

Beijing Baihui Biochemical Pharmaceutical Co.,Ltd, a high-tech enterprise locating in Beijing Zhongguancun Science & Technology Garden, and director of CBPIA( China Biochemical Pharmaceutical Industry Association), is a professional Omega-3(ethylpolyenoate)fatty acid medicine manufacturer.

In 2001, Baihui’s products of preparation drugs and soft capsule all passed the GMP accreditation approved by China FDA. In 2006, Baihui passed the GMP re-examination.

In 2003, Baihui’s products, ethyl polyenoate soft capsule and bombyx mori oil ethyl linolenate soft capsule are listed in “ the China Nation Level Torch Plan” approved by China Science and Technology Department.

Our products, ethyl polyenoate soft capsule with Mailekang TM  gained the Gold Medal in the International Medicine Science and Technology Fair in Jakarta.

In 2004, depending on Baihui’s innovation, Baihui succeeded in developing the new production method and new equipment for production of high DHA (Docosahexaenic Acid) content  type of Omega-3 ethyl esters drug, and drafted and revised the original China standard on Omega-3 drug to make it reach the Europe and America international level, and lead in the high DHA concentration type of drug field in the world, And uniquely begin to sell this type of drug in China market. It will make contribution for people’s health in China and in the word.

Because DHA is easy to be oxidated, spoiled, polymerized and sediment during the processing, the high DHA type of drug is hard to produce, the high concentration DHA type of medicine is not used in Europe and America market, the high concentration DHA type medicine is lack in the world.

Beijing Baihui Biochem Pharm Company succeeded in developing the new production method and new equipment ,and overcomed difficulty, produced the high DHA concentration type of medicine with DHA and EPA over 84%(ratio of DHA: EPA is 2:1) in bulk. Baihui Biopharm is leading in production of high DHA concentration type of medicine without  polymerization, spoilage, deposition not only in China but also in the world. Baihui have made clinical trial on ethyl polyenoate drug in several state-owned hospitals in Beijing city, several decades of hospital have selected this products as the prescribed drug, from year 1998 continual several years, it is listed in the category of Beijing public health care drug. The customers from several decades of countries came to Baihui Company to purchase ethyl polyenoate soft capsule, this type of drug is famous in the world , Baihui can supply the customers at home and abroad with the high DHA type of Omega-3 drug.

In 2004, Baihui produced and sold the Bombyx Mori Oil a-Ethyl Linolenate exclusively, it is natural biochemical drug extracted from silkworm pup, it is “green”no pollution Omega-3 fatty acid drug, China is large scale of the silk producing country, this product is special product in China, and has the efficacy of decreasing liver lipids, preventing and treating fatty liver.  


版权所有:北京百慧生化制药有限责任公司

(C) 2005-2008   留言查看

技术支持:香港经济网新闻中心